REQUEST A DEMO
Total
USD $0.00
« Back to previous page

Malaysia Pharma and Healthcare Report 2021-2022

An EMIS Insights Industry Report
EMIS is an ISI Emerging Markets Group Company
Date: March 2021
Pages: 85
Available in: English

Malaysia has one of the ASEAN region’s most developed pharmaceuticals and healthcare sectors. Malaysia has a two-tiered system in which the government, under the Ministry of Health, operates healthcare facilities and regulates medical practice in private facilities. Malaysia’s leading private hospitals are well-equipped and well-staffed, giving Malaysians access to the full range of specialist care services, and attracting a growing number of medical tourists to the country. Malaysia is a significant exporter of medical supplies, especially for medical and surgical gloves in which Malaysia has a commanding global market share. Malaysia is a net importer of medicines but is gradually growing its profile as an exporter in the niche halal pharmaceuticals segment.

 

This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for Malaysia. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

  • Understand the key elements at play in the healthcare and pharmaceutical sector in Malaysia
  • Access forecasts for growth in the sector
  • View key data on healthcare spending and health insurance in Malaysia
  • Crystallise the forces both driving and restraining this sector in Malaysia
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in Malaysia
  • Build a clear picture of trends and issues for subsectors (medical institutions, pharmaceuticals manufacturing and distribution channels)

See below for a complete table of report contents:

Malaysia Pharma and Healthcare Report 2021-2022 - Page 1
Buy full report USD 495.00 Payment methods include:

DOWNLOAD A SAMPLE
Have a question?

Email us at: customerenquiries@emis.com

SEE BELOW FOR A COMPLETE TABLE OF REPORT CONTENTS:

Malaysia Pharma and Healthcare Report 2021-2022 -  Page 3
Malaysia Pharma and Healthcare Report 2021-2022 -  Page 4
Malaysia Pharma and Healthcare Report 2021-2022 -  Page 20
Malaysia Pharma and Healthcare Report 2021-2022 -  Page 21
ONCE YOU HAVE COMPLETED YOUR PURCHASE,
YOU WILL BE ABLE TO DOWNLOAD THIS REPORT IMMEDIATELY AS A PDF
If you have any questions, please contact customerenquires@emis.com
Buy full report
Need ongoing access to company, industry or country information?